Heonju Lee

CEO and Founder at CARBio Therapeutics

Presenter

Founder and CEO, Heon-ju Lee (Ph.D.), possesses extensive expertise and experience in the field of clinical immunology and pharmaceuticals. - Possesses 35 years of practical experience in bio research, business planning, and CAR-T cell therapy R&D, as well as a career in global business development. - Majored in Mycology, Biochemistry, and Genetics at the Department of Microbiology, Seoul National University. - Served as Head of the Health Industry Division at the Korea Institute of Health and Welfare, Head of the Toxicology Screening Center at the National Institute of Safety Evaluation, Korea Research Institute of Chemical Technology, and Head of the Innovation Policy & Public Relations Department. - Experience in business planning and development, including serving as a research team leader at CJ, Samsung Medical Center, and Samsung Advanced Institute of Technology. - The team is composed of five Ph.D.-level professional researchers specializing in biology, biochemistry, immunology, pharmacy, and veterinary medicine. - The six expert members of the Scientific Advisory Board consist of professors at Osong KBio Foundation, Seoul National University College of Pharmacy and Department of Biology, and Chungnam National University College of Medicine, as well as global bio experts active in Taiwan and Japan. Composed of Ph.D.-level advisors with practical experience at the U.S. FDA, they are responsible for resolving complex issues in the field of immunology and providing professional scientific support through global networks.